CommercialCoverageMedium impact
Polio Vaccine (CPB 0402, reviewed 2026-07-07)
Aetna·Allergy & Immunology, Family Medicine, General Practice +2 more·Medical Policy
Effective date
Jul 7, 2026
We identified it
Aug 13, 2026
Summary
Aetna's Polio Vaccine policy (CPB 0402) reaffirms coverage of FDA-approved inactivated polio vaccine (IPV) as medically necessary preventive care following CDC/ACIP recommendations. The policy clarifies that oral polio vaccine (OPV) is no longer recommended or available in the U.S., establishes specific dosing schedules for children (4 doses) and adults (primary series plus potential single booster for high-risk exposure), and specifies billable CPT codes for vaccine administration and combined vaccines containing IPV.
Action Required
By 2026-07-07: Billing team must verify that billing system is configured to recognize and process CPT codes 90698, 90713, 90723, 90460, 90461, 90471, and 90472 for polio vaccine claims. Ensure that any prior authorizations or coverage rules in the system reflect Aetna's coverage of IPV only (not OPV). Review claim templates to ensure providers document the appropriate ICD-10 codes (Z20.89 for exposure/contact or Z23 for immunization encounter). Note the plan limitation: Some Aetna plans exclude coverage of immunizations required for travel or work-related risk—verify individual benefit plan descriptions before processing travel-related or occupational polio vaccination claims to avoid denials. If any claims are currently configured to cover OPV, update those rules immediately as OPV is no longer available. Front desk staff should be aware that accelerated schedules may be used for travel situations, which must be documented for medical necessity support.